Gilead Sciences (GILD) 104.18 $GILD Forget Google: 5 Top

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 104.18 $GILD

Forget Google: 5 Top Stocks With Earnings Thursday
at Investor's Business Daily - 1 hr 10 mins ago
Tech titan Google (GOOGL) will make headlines with its quarterly earnings after the close on Thursday. But Google's growth is sluggish and the stock is lackluster. Check out these five stocks with better performance than the search giant, including...
AMZN: 389.80 (-1.38), PCYC: 256.98 (-0.77), MO: 52.12 (+0.02), ALK: 64.31 (-0.62), LUV: 42.85 (-0.18), SBUX: 48.33 (-0.04), GILD: 104.18 (-1.02), ALXN: 188.19 (+1.41), GM: 37.16 (unch), GOOGL: 549.18 (+6.26), ABBV: 64.52 (+0.91), PG: 83.09 (+0.01), MSFT: 42.98 (+0.35), DOW: 50.02 (+0.37)

Final Glance: Biotechnology companies
AP - 2 hrs 28 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

The Fed And The Markets: Where To Invest In The Current Environment
Nicholas P. Cheer - at Seeking Alpha - Wed Apr 22, 1:08PM CDT

JNJ: 100.43 (+0.13), BIIB: 423.57 (+1.46), BOND: 109.71 (-0.57), USB: 42.83 (+0.33), GILD: 104.18 (-1.02), AIG: 56.58 (-0.06), AAPL: 128.62 (+1.71), TLT: 127.72 (-1.98)

The Naked Truth
Eric Parnell, CFA - at Seeking Alpha - Wed Apr 22, 1:04PM CDT

SPLV: 37.76 (+0.11), IEF: 107.92 (-0.63), EZU: 39.22 (unch), XLU: 44.45 (+0.09), TLT: 127.72 (-1.98), XLV: 74.35 (+0.12), EWJ: 13.27 (+0.10), XLP: 49.35 (+0.03), SPY: 210.63 (+1.03), GILD: 104.18 (-1.02), GLD: 113.83 (-1.55), PFF: 39.98 (+0.02), VNQ: 82.23 (+0.17), BWX: 53.17 (-0.07), FXI: 52.39 (+0.89)

Gilead hopes to drive international demand for hep C drugs by giving some away
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 1:01PM CDT

GILD: 104.18 (-1.02), ABBV: 64.52 (+0.91)

Midday Glance: Biotechnology companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 22, 12:21PM CDT
Amgen's (AMGN) first quarter 2015 results were impressive and the company raised its earnings outlook for the year.
BIIB: 423.57 (+1.46), ALNY: 118.00 (-2.70), GILD: 104.18 (-1.02), MDCO: 27.84 (+0.25), AMGN: 169.10 (+0.64), AMPE: 2.89 (+0.20), ABBV: 64.52 (+0.91), ATHX: 1.34 (+0.01)

Gilead Sciences (GILD) Stock Is the 'Chart of the Day'
at The Street - Wed Apr 22, 11:20AM CDT
Gilead Sciences (GILD) stock is the Trifecta Stocks Team's 'Chart of the Day.'
GILD: 104.18 (-1.02)

Gilead Buying Vertex? What's The Use?
Kanak Kanti De - at Seeking Alpha - Wed Apr 22, 10:39AM CDT

VRTX: 132.85 (+0.65), GILD: 104.18 (-1.02)

Early Glance: Biotechnology companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Amgen Earnings Reveals Ugly Truth About Drug Pricing and Sales 'Growth'
at The Street - Wed Apr 22, 9:18AM CDT
It's common for drug companies to raise the price of their existing products once or twice per year, every year. The price increases far outpace the rate of inflation.
BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:30AM CDT
The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals
JNJ: 100.43 (+0.13), BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), ANTH: 4.79 (+0.10), GERN: 4.20 (-0.04)

Gilead Sciences Vs. AbbVie: Which Is A Better Buy?
Mycroft - at Seeking Alpha - Wed Apr 22, 7:49AM CDT

JNJ: 100.43 (+0.13), ABT: 48.35 (+1.23), PCYC: 256.98 (-0.77), GILD: 104.18 (-1.02), SHPG: 253.58 (+3.70), ABBV: 64.52 (+0.91)

Gilead Sciences
at Investor's Business Daily - Tue Apr 21, 5:48PM CDT
Gilead Sciences (GILD) stock rose 4.5% after Bernstein said it should buy cystic fibrosis drugmaker Vertex (VRTX), which rose 5%.
VRTX: 132.85 (+0.65), GILD: 104.18 (-1.02)

SmarTrend Watching for Potential Pullback in Shares of Gilead Sciences After 4.52% Gain
Comtex SmarTrend(R) - Tue Apr 21, 3:46PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $100.89 to a high of $105.71. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $104.72 on volume of 19.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GILD: 104.18 (-1.02)

Gilead Sciences Rises 4.52% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 21, 3:45PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $100.89 to a high of $105.71. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $104.72 on volume of 19.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GILD: 104.18 (-1.02)

Dow Extends Losses; Travelers Falls After Missing Earnings Estimates
at The Street - Tue Apr 21, 2:16PM CDT
Stocks are mixed on Tuesday as disappointing earnings drag on overall markets.
HOG: 56.23 (+0.51), VRTX: 132.85 (+0.65), UTX: 116.96 (+0.01), MYL: 72.40 (-1.67), PKG: 70.68 (+1.66), UA: 82.27 (-1.25), GILD: 104.18 (-1.02), IBM: 165.36 (+1.10), DD: 71.44 (+0.75), TEVA: 63.01 (-1.15), VZ: 49.57 (+0.40), BHI: 67.07 (-0.28), TRV: 102.02 (+0.14)

5 Reasons To Consider Gilead
David Sims - at Seeking Alpha - Tue Apr 21, 1:02PM CDT

GILD: 104.18 (-1.02), ABBV: 64.52 (+0.91)

Most active Nasdaq-traded stocks
AP - Tue Apr 21, 12:45PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
GILD: 104.18 (-1.02), AMD: 2.28 (-0.07), FB: 84.63 (+1.01), BIOC: 3.15 (+0.02), CMCSK: 58.35 (-0.09), AXPW: 0.04 (unch), VLTC: 15.14 (-1.04), MSFT: 42.98 (+0.35), ZNGA: 2.51 (+0.02), AAPL: 128.62 (+1.71), CMCSA: 58.76 (-0.08), CSCO: 28.62 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 4

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
DAHON's Tech: Crafting Folders That Ride Like Road Bikes

Updated Category News Views 4

The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...

Continue Reading
Sierra Ridge Advisors Join Gateway Financial Milestone

Updated Category News Views 5

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...

Continue Reading
Menopause Policy Advocacy Takes Center Stage in DC

Updated Category News Views 5

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Continue Reading
IRS Views Challenge Tax-Engineered Healthcare Schemes

Updated Category News Views 4

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Continue Reading
Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 5

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
Bellissima Bags Allure Award for Curly Hair Tool

Updated Category News Views 4

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
Vetology Reinvents AI Models for Veterinary Radiology

Updated Category News Views 5

Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...

Continue Reading

Top 5 Most Recently Viewed Articles

WHO's Tobacco Control Framework Faces Criticism on Anniversary

Updated Category News Views 245

WHO's Tobacco Control Framework Under Scrutiny As the World Health Organization (WHO) commemorates the 20th anniversary of its Framework Convention on Tobacco Control (FCTC), this milestone has surprisingly ignited a wave of criticism from health experts and advocates. Rather than celebrating success, a recent panel organized by the Taxpayers Protection Alliance (TPA)...

Continue Reading
True Global Ventures Expands Horizons with New CMS Licence

Updated Category News Views 258

True Global Ventures Expands Horizons with New CMS Licence True Global Ventures 4 Plus Pte. Ltd. ("TGV") is excited to share that it has received a Capital Markets Services ("CMS") licence from the Monetary Authority of Singapore ("MAS"). This important step enables TGV to conduct regulated fund management activities beyond solely managing venture capital funds. New...

Continue Reading
TMC the Metals Company Inc. Class Action: Key Details to Know

Updated Category News Views 134

Understanding the TMC the Metals Company Inc. Class Action In a significant class action lawsuit, investors of TMC the Metals Company Inc. are urged to act swiftly due to an important lead plaintiff deadline looming on the horizon. This opportunity is particularly crucial for investors who may have incurred losses exceeding $100,000 during a specified period. Rosen Law...

Continue Reading
d'Alba: The Skincare Brand Poised for Global Recognition

Updated Category News Views 365

Revealing d'Alba: Korea's Skincare Gem d'Alba has emerged as a leading name in the skincare industry, marking its place as Korea's top revenue-generating independent skincare brand. Alongside its domestic triumphs, d'Alba is keenly focused on expanding its reach internationally, transforming from a hidden gem to a globally recognized player in the K-beauty market....

Continue Reading
Cloudastructure Ventures into Construction with New Security Tech

Updated Category News Views 143

Cloudastructure Launches Innovative Solutions for Construction Security Cloudastructure, Inc. (Nasdaq: CSAI), a leader in AI surveillance and remote monitoring, has made a significant entry into the construction market. This movement is highlighted by the first sale of its cutting-edge Mobile Surveillance Trailer Alpha™, designed in collaboration with Flex Security™....

Continue Reading